Feature Channels: Vaccines

Filters close
Newswise: How T cells combat tuberculosis
Released: 6-Feb-2024 11:05 AM EST
How T cells combat tuberculosis
La Jolla Institute for Immunology

Scientists at La Jolla Institute for Immunology (LJI) have uncovered important clues to how human T cells combat the bacterium that causes tuberculosis.

Released: 1-Feb-2024 12:05 PM EST
American Society of Anesthesiologists welcomes improvements to No Surprises Act IDR process
American Society of Anesthesiologists (ASA)

The American Society of Anesthesiologists (ASA) commends the Centers for Medicare & Medicaid Services (CMS) for taking positive steps towards returning balance to the independent dispute resolution (IDR) process of the No Surprises Act (NSA) through a recently proposed rule.

Released: 30-Jan-2024 2:05 PM EST
Our winter of discontent: Get the latest news on the flu in the Influenza channel
Newswise

The latest research and expertise on the flue can be found in the Influenza channel on Newswise.

Released: 30-Jan-2024 1:05 PM EST
DNA particles that mimic viruses hold promise as vaccines
Massachusetts Institute of Technology (MIT)

Using a virus-like delivery particle made from DNA, researchers from MIT and the Ragon Institute of MGH, MIT, and Harvard have created a vaccine that can induce a strong antibody response against SARS-CoV-2.

Newswise: Soap bark discovery offers a sustainability booster for the global vaccine market
Released: 26-Jan-2024 10:05 AM EST
Soap bark discovery offers a sustainability booster for the global vaccine market
John Innes Centre

A valuable molecule sourced from the soapbark tree and used as a key ingredient in vaccines, has been replicated in an alternative plant host for the first time, opening unprecedented opportunities for the vaccine industry.

   
Newswise: Single Dose Typhoid Conjugate Vaccine (TCV) Provides Lasting Efficacy in Children
24-Jan-2024 4:05 PM EST
Single Dose Typhoid Conjugate Vaccine (TCV) Provides Lasting Efficacy in Children
University of Maryland School of Medicine

A single dose of the typhoid conjugate vaccine, Typbar TCV®, provides lasting efficacy in preventing typhoid fever in children ages 9 months to 12 years old, according to a new study conducted by researchers at University of Maryland School of Medicine’s (UMSOM) Center for Vaccine Development and Global Health (CVD) and led by in-country partners at the Malawi-Liverpool Wellcome Trust (MLW) Clinical Research Programme.

Newswise:Video Embedded beyond-bmi-ohio-state-expert-says-complete-approach-to-measuring-health-is-better
VIDEO
Released: 23-Jan-2024 12:00 PM EST
Beyond BMI, Ohio State expert says complete approach to measuring health is better
Ohio State University Wexner Medical Center

For decades, the number on a scale has been a key factor in deciding whether a person is healthy or not. But weight alone doesn’t paint a complete picture of one’s health.

Released: 22-Jan-2024 11:05 AM EST
American Society of Anesthesiologists (ASA) Welcomes Vince Loffredo, Ed.D., as Chief Learning Officer
American Society of Anesthesiologists (ASA)

In a strategic move, ASA has hired Vince Loffredo, Ed.D., as its new Chief Learning Officer, where he will oversee the Education, Meetings, and Publications departments, as well as serve as a vital member of ASA’s CEO team.

Released: 19-Jan-2024 1:05 PM EST
Don't wait for an emergency to get the latest emergency medicine news
Newswise

Find the latest research and features on emergency medicine in the Emergency Medicine channel on Newswise.

       
Newswise: Remodeling the immune system to fight tuberculosis
Released: 19-Jan-2024 7:05 AM EST
Remodeling the immune system to fight tuberculosis
University of Massachusetts Amherst

Tuberculosis, caused by the bacterium Mycobacterium tuberculosis (Mtb) kills upwards of 1.6 million people a year, making it one of the leading causes of death by an infectious agent worldwide—and that number is only growing larger.

Newswise: We Need a Staph Vaccine: Here’s Why We Don’t Have One
11-Jan-2024 11:00 AM EST
We Need a Staph Vaccine: Here’s Why We Don’t Have One
University of California San Diego

A vaccine for Staphylococcus aureus, one of the most common bacterial infections, would be a game changer for public health. No vaccine candidates have succeeded in clinical trials, but nobody knows why. Researchers at UC San Diego may have figured it out.

Released: 16-Jan-2024 7:05 AM EST
A call for improved CDC communication on adult immunization
CUNY Graduate School of Public Health and Health Policy

In an editorial in the Annals of Internal Medicine, CUNY SPH Distinguished Lecturer Scott Ratzan, Senior Scholar Ken Rabin, and colleagues call for the Centers for Disease Control and Prevention (CDC) to “raise its persuasive communications game” on adult immunization to clinicians and the public.

Newswise: Studies examine different responses to SARS-CoV-2 variants
Released: 12-Jan-2024 12:05 PM EST
Studies examine different responses to SARS-CoV-2 variants
UT Southwestern Medical Center

Two studies led by a researcher at UT Southwestern Medical Center show the effects of different SARS-CoV-2 variants on lung tissue, revealing what may cause some COVID-19 infections to be more severe than others.

Not for public release

This news release is embargoed until 11-Jan-2024 1:00 PM EST Released to reporters: 4-Jan-2024 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 11-Jan-2024 1:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Study: Pregnant Women More Likely to Get COVID-19 Vaccine if They Got Other Pregnancy Immunizations
Released: 11-Jan-2024 10:05 AM EST
Study: Pregnant Women More Likely to Get COVID-19 Vaccine if They Got Other Pregnancy Immunizations
Cedars-Sinai

Women who received standard recommended immunizations during their pregnancy were more likely to accept the COVID-19 vaccine, according to new research from Cedars-Sinai. Investigators also identified disparities in vaccination linked to race and insurance status.

Released: 11-Jan-2024 8:50 AM EST
mRNA technology could be possible treatment for rare diseases
University College London

The research, published in Science Translational Medicine, found that messenger RNA (mRNA) could be used to correct a rare liver genetic disease known as argininosuccinic aciduria in a mouse model of the disease.

Released: 10-Jan-2024 10:20 AM EST
Hackensack Meridian Center for Discovery and Innovation Welcomes New Board Member, Dr. Daria Hazuda
Hackensack Meridian Health

Renowned scientist in vaccine and infectious disease research joins prestigious board of visionary leaders



close
2.46274